Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 29-38

  Kariv, Ilona ^a   Truneh, Alemseged ^a   Sweet, Raymond W ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD30 ANTIGEN; CD86 ANTIGEN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; BASE SEQUENCE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; L CELLS (CELL LINE); MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; SEQUENCE ALIGNMENT;

EID: 0029951647     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Altman, A., T. Mustelin, and K. M. Coggeshall. 1990. T lymphocyte activation: A biological model of signal transduction. Crit. Rev. Immunol. 10:347.
2. Rudd, C. E., O. Janssen, Y.-C. Cai, A. J. da Silva, M. Raab, and K. V. S. Prasad. 1994. Two-step TCR ζ/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol. Today 15:225.
3. Shimizu, Y., G. A. van Seventer, K. J. Horgan, and S. Shaw. 1990. Roles of adhesion molecules in T-cell recognition: Fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding and costimulation. Immunol. Rev. 114:109.
4. Linsley, P. S., and J. A. Ledbetter. 1993. The role of CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
5. Allison, J. P. 1994. CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 6:414.
6. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
7. Harlan, D. M., R. Abe, K. P. Lee, and C. June. 1995. Short analytical review: potential role of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin. Immunol. Immunopathol. 75:99.
8. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
9. Lindsten, T., K. P. Lee, E. S. Harris, B. Petryniak, N. Craighead, P. J. Reynolds, D. B. Lombard, G. J. Freeman, L. M. Nadler, G. S. Gray, C. B. Thomson, and C. H. June. 1993. Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 15:3489.
10. Linsley, P. S., W. Brady, M. Urnes, L. S. Crosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
11. Linsley, P. S., S. G. Nadler, J. Bajorath, R. Peach, H. T. Leung, J. Rogers, J. Bradshaw, M. Stebbins, G. Leytze, W. Brady, A. R. Malacko, H. Marquardt, and S.-Y. Shaw. 1995. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). J. Biol. Chem. 270:15417.
12. Linsley, P. S., J. L. Greene, P. Tan, J. Bradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595.
13. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
14. Walunas, T. L., D. L. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
15. Gribben, J. G., G. J. Greeman, V. Boussiotis, P. Rennert, C. L. Jellis, E. Greenfield, M. Barber, V. A. Restivo, Jr., X. Ke, G. S. Gray, and L. M. Nadler. 1995. CTLA-4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92:811.
16. Linsley, P. S. 1995. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182:289.
17. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84:8573.
18. Gross, J. A., St. T. John, and J. P. Allison. 1990. The murine homologue of the T lymphocyte antigen CD28: molecular cloning and cell surface expression. J. Immunol. 144:3201.
19. Clark, G. J., and M. J. Dallman. 1992. Identification of a cDNA encoding the rat CD28 homologue. Immunogenetics 35:54.
20. Pastori, R. L., K. F. Milde, and R. Alejandro. 1994. Molecular cloning of the dog homologue of the lymphocyte antigen CD28. Immunogenetics 39:373.
21. Young, J. R., T. F. Davidson, C. A. Tregaskes, M. C. Rennie, and O. Vainio. 1994. Monomeric homologue of mammalian CD28 is expressed on chicken T cells. J. Immunol. 152:3848.
22. Brunet, J. F., F. Denizot, M. F. Luciani, D. M. Roux, M. Suzan, M. G. Mattei, and P. Golstein. 1987. A new member of the immunoglobulin superfamily - CTLA-4-Ig. Nature 328:267.
23. Dariavach, P., M. G. Mattei, P. Golstein, and M. P. Lefranc. 1988. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domain. Eur. J. Immunol. 12:1901.
24. Harper, K., C. Balzano, E. Rouvier, M. G. Mattei, M. F. Luciani, and P. Golstein. 1991. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147:1037.
25. Truneh, A., M. Reddy, P. Ryan, S. D. Lyn, C. Eichman, D. Couez, M. R. Hurle, R. P. Sekaly, D. Olive, and R. Sweet. 1996. Differential recognition by CD28 of its cognate counter receptor CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis. Int. Immunol. 3:321.
26. Freeman, G. J., A. S. Fredman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
27. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
28. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905.
29. Chen, C., A. Gault, L. Shen, and N. Nabavi. 1994. Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule. J. Immunol. 152:4929.
30. Freeman, G. J., G. S. Gray, C. D. Gimmi, D. B. Lombard, L. J. Zhou, M. White, J. D. Fingeroth, J. G. Gribben, and L. M. Nadler. 1991. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174:625.
31. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo, Jr., L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
32. Bajorath, J., R. J. Peach, and P. S. Linsley. 1994. Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86). Protein Science 3:2148.
33. Morton, P. A., X.-T. Fu, J. A. Stewart, K. S. Giacoletto, S. L. White, C. E. Leysath, R. J. Evans, J.-J. Shieh, and R. W. Karr. 1996. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J. Immunol. 156:1047.
34. Peach, R. J., J. Bajorath, W. Brady, G. Leytze, J. Greene, J. Naemura, and P. S. Linsley. 1994. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 180:2049.
35. Linsley, P. S., J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
36. Nunes, J., S. Klasen, M. Ragueneau, C. Pavon, D. Couez, C. Mawas, M. Bagnasco, and D. Olive. 1993. CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int. Immunol. 5:311.
37. Couez, D., F. Pages, M. Ragueneau, J. Nunes, S. Klasen, C. Mawas, A. Truneh, and D. Olive. Functional expression of human CD28 in murine T cell hybridomas. Mol. Immunol. 31:47.
38. Smith, R. I. F., M. J. Coloma, and S. L. Morrison. 1995. Addition of a μ-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4. J. Immunol. 154:2226.
39. Smith R. I., and S. L. Morrison. 1994. Recombinant polymeric IgG: an approach to engineering more potent antibodies. Biotechnology 12:683.
40. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. 1988. Current Protocols in Molecular Biology. Greene Publishing Associates and Wiley-Interscience, New York, NY, pp. 16.13.1-16.13.3.
41. Wigler, M., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacy, T. Maniatis, S. Silverstein, and R. Axel. 1979. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:777.
42. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T-cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027.
43. Fargeas, C. A., A. Truneh, M. Reddy, M. Hurle, R. Sweet, and R.-P. Sekaly. 1995. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA-4. J. Exp. Med. 182:667.
44. Lanier, L. L., S O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
45. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7.1 and anti-B7.2 monoclonal Abs on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
46. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathway: application to autoimmune disease therapy. Cell 80:1.
47. Nakajima, A., M. Azuma, S. Kodera, S. Nuriya, A. Terashi, M. Abe, S. Hirose, T. Shirai, H. Yagita, and K. Okumura. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immunol. 25:3060.
48. ras. J. Exp. Med. 180:1067.
49. Freeman, G. J., V. Boussiots, A. Anumathan, G. M. Bernstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7.1 preferentially costimulate the initial production of IL-4. Immunity 2:523.
50. Petro, T. M., S. S. A. Chen, and R. B. Panther. 1995. Effect of CD80 and CD86 on T-cell cytokine production. Immunol. Inv. 24:965.